Explore more publications!

Press Releases

WHO cautions against increase of chikungunya illness

WHO cautions against increase of chikungunya illness

 National Personal Chef Day Spotlights a $16.88B Industry Transforming Luxury Dining at Home
EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

EU Balance of Payments and International Investment Position statistical sources and methods - B.o.p. and i.i.p. e-book

NY Rum Fest & Conference takes place in Brooklyn on June 7th
EDITORIAL: “But who will pick our olives?” – Demographic decline and refugee inclusion

EDITORIAL: “But who will pick our olives?” – Demographic decline and refugee inclusion

Statement on the Cabinet meeting of Wednesday, 17 September 2025

Statement on the Cabinet meeting of Wednesday, 17 September 2025

Public Health Action Network Is A Partnering Organization for the  'Healthy Indoor Air' Event at the UN General Assembly
OSE Immunotherapeutics Board Urges Support for Value-Driving Strategy and Open-Minded Governance -  Publication of Circular for Combined Annual General Meeting of  September 30, 2025
Valneva Reports Half Year 2025 Financial Results and Provides Corporate Updates
Valneva Announces FDA’s Decision to Suspend License of Chikungunya Vaccine IXCHIQ® in the U.S.
Valneva Announces Removal of FDA-Recommended Pause on Use of Chikungunya Vaccine IXCHIQ® in Elderly and Updates to the Prescribing Information
Native American Photography Book 'Dancing for Our Tribe' by Sharon Hoogstraten
Brunch Is the New NYC Ritual: Here's Where to Find the Most Delicious One This Weekend
Valneva Reports Positive Six-Month Antibody Persistence and Safety Phase 2 Results in Children for its Single-Shot Chikungunya Vaccine IXCHIQ®
Combined General Meeting of June 13, 2025
Combined General Meeting of June 11, 2025
Valneva Provides Update on Recommended Use of IXCHIQ® by Elderly Individuals in the United States
Nüspace Celebrates 20 Years: From a Taxi Garage to a Montreal Design Destination
Valneva Provides Update Following European Medicines Agency Announcement on Use of IXCHIQ® in Elderly
Valneva Provides Update on ACIP Recommendation for its Chikungunya Vaccine IXCHIQ® Among U.S. Travelers

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions